NanoScience Technology Center, University of Central Florida, Orlando, Florida, United States of America.
PLoS One. 2012;7(4):e35326. doi: 10.1371/journal.pone.0035326. Epub 2012 Apr 9.
Bacterial infections are still a major global healthcare problem. The quick and sensitive detection of pathogens responsible for these infections would facilitate correct diagnosis of the disease and expedite treatment. Of major importance are intracellular slow-growing pathogens that reside within peripheral leukocytes, evading recognition by the immune system and detection by traditional culture methods. Herein, we report the use of hybridizing magnetic nanosensors (hMRS) for the detection of an intracellular pathogen, Mycobacterium avium spp. paratuberculosis (MAP). The hMRS are designed to bind to a unique genomic sequence found in the MAP genome, causing significant changes in the sample's magnetic resonance signal. Clinically relevant samples, including tissue and blood, were screened with hMRS and results were compared with traditional PCR analysis. Within less than an hour, the hMRS identified MAP-positive samples in a library of laboratory cultures, clinical isolates, blood and homogenized tissues. Comparison of the hMRS with culture methods in terms of prediction of disease state revealed that the hMRS outperformed established culture methods, while being significantly faster (1 hour vs 12 weeks). Additionally, using a single instrument and one nanoparticle preparation we were able to detect the intracellular bacterial target in clinical samples at the genomic and epitope levels. Overall, since the nanoparticles are robust in diverse environmental settings and substantially more affordable than PCR enzymes, the potential clinical and field-based use of hMRS in the multiplexed identification of microbial pathogens and other disease-related biomarkers via a single, deployable instrument in clinical and complex environmental samples is foreseen.
细菌感染仍然是一个主要的全球医疗保健问题。快速和敏感地检测导致这些感染的病原体将有助于正确诊断疾病并加快治疗速度。最重要的是,那些在周围白细胞内缓慢生长的病原体,逃避了免疫系统的识别和传统培养方法的检测。在此,我们报告了杂交磁纳米传感器(hMRS)在检测一种细胞内病原体——牛分枝杆菌副结核病(MAP)中的应用。hMRS 被设计用于与 MAP 基因组中发现的独特基因组序列结合,导致样品磁共振信号发生显著变化。hMRS 对包括组织和血液在内的临床相关样本进行了筛选,并将结果与传统 PCR 分析进行了比较。在不到一个小时的时间内,hMRS 从实验室培养物、临床分离物、血液和匀浆组织的文库中识别出 MAP 阳性样本。hMRS 在预测疾病状态方面与培养方法的比较表明,hMRS 优于传统的培养方法,同时速度明显更快(1 小时与 12 周)。此外,使用单一仪器和一种纳米颗粒制剂,我们能够在临床样本中检测到细胞内细菌靶标在基因组和表位水平上的存在。总的来说,由于纳米颗粒在各种环境条件下都很稳定,而且比 PCR 酶便宜得多,因此 hMRS 有望在临床上和复杂环境样本中通过单一、可部署的仪器,用于微生物病原体和其他与疾病相关的生物标志物的多重识别,具有很大的临床和现场应用潜力。